Real-world effectiveness of casirivimab and imdevimab among patients diagnosed with COVID-19 in the ambulatory setting: a retrospective cohort study using a large claims database

OBJECTIVE: To assess the real-world effectiveness of casirivimab and imdevimab (CAS+IMD) versus no COVID-19 antibody treatment among patients diagnosed with COVID-19 in the ambulatory setting, including patients diagnosed during the Delta-dominant period prior to Omicron emergence. DESIGN: Retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussein, Mohamed, Wei, Wenhui, Mastey, Vera, Sanchez, Robert J, Wang, Degang, Murdock, Dana J, Hirshberg, Boaz, Weinreich, David M, Jalbert, Jessica J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764096/
https://www.ncbi.nlm.nih.gov/pubmed/36535724
http://dx.doi.org/10.1136/bmjopen-2022-064953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764096/
https://www.ncbi.nlm.nih.gov/pubmed/36535724
http://dx.doi.org/10.1136/bmjopen-2022-064953

Ejemplares similares